For decades, circular RNAs (circRNAs) were dismissed as "transcriptional noise" or rare errors in the splicing process. However, a growing body of evidence reveals that these molecules are not accidents, but a sophisticated class of regulatory elements. Unlike linear messenger RNA, which carries the genetic code to the ribosome, circRNAs form covalently closed loops. This single geometric shift—the removal of free 5' and 3' ends—grants them a level of biological persistence that linear transcripts cannot match.
The Geometry of Persistence
The primary reason circRNAs have become a focal point in research is their inherent resistance to enzymatic degradation. Most cellular exonucleases, the enzymes responsible for recycling RNA, require a free end to begin their work. By closing the loop, circRNAs become "invisible" to these enzymes.
As noted by Guifang Xu and colleagues in their study of circCCDC66, this stability allows circRNAs to accumulate in the cellular environment and exert sustained influence over biological processes. This structural robustness is often validated in the lab using RNase R, an exonuclease that digests linear RNA but leaves circularized molecules intact. This biochemical "stress test" is the gold standard for distinguishing true circular isoforms from their linear counterparts, as described by Meihuan Chen in research on pediatric β-thalassemia.
Molecular Sponging and Signaling Hubs
Once stabilized, circRNAs function primarily as "molecular sponges." They possess binding sites for microRNAs (miRNAs), which are small molecules that typically silence target genes. By sequestering these miRNAs, circRNAs effectively "brake the brakes," allowing oncogenes or other growth factors to be expressed.
For example, Xiaying Zheng demonstrated that circSEPT9 facilitates triple-negative breast cancer by neutralizing tumor-suppressing miRNAs, thereby activating the LIF/Stat3 signaling pathway. Similarly, Xuan Guo found that circITCH acts as a tumor suppressor in liver cancer by sponging miR-184.
Beyond sponging, circRNAs can act as protein scaffolds or even templates for translation. Jun Zheng identified circFOXK2 as a "dual-threat" molecule that both sponges miRNAs and encodes a novel protein to drive metabolic reprogramming in cancer cells.
The Liquid Biopsy Advantage
The stability of circRNAs makes them ideal candidates for non-invasive diagnostics, or "liquid biopsies." Linear RNA is highly susceptible to degradation in the bloodstream, making it a fickle biomarker. In contrast, the closed-loop structure of circRNAs—often further protected within exosomes (extracellular vesicles)—allows them to survive the harsh environment of maternal circulation or peripheral blood.
Yonggang Zhang highlighted this utility in the context of preeclampsia, where circCRAMP1L serves as a robust biomarker because it resists the exonucleases that would otherwise destroy linear signals. In critical care, Chang Fu Tian identified exosomal circRNAs as stable indicators for early sepsis diagnosis, providing a window into the body's physiological state that traditional RNA cannot offer.
Identifying the Circle
To find these molecules among the vast sea of linear RNA, researchers look for the back-splice junction. This is the specific point where the 3' end of an exon joins to the 5' end of an upstream exon—a "head-to-tail" connection that does not exist in linear mRNA.
As explained by Peihong Wang in studies of rice immunity, researchers use divergent PCR primers. While standard convergent primers point toward each other on a linear strand, divergent primers point away from each other. They will only produce a signal if the template is circular, allowing the primers to "meet" as they wrap around the loop. This physical verification, combined with Sanger sequencing of the junction, ensures that the identified sequence is a true covalently closed circle.
By leveraging their unique geometry, circular RNAs have evolved from biological curiosities into a fundamental layer of the epitranscriptome, offering new ways to track, understand, and eventually treat complex diseases.